Index RUT
P/E -
EPS (ttm) -3.25
Insider Own 13.68%
Shs Outstand 53.68M
Perf Week -3.41%
Market Cap 1.10B
Forward P/E -
EPS next Y -4.27
Insider Trans -0.14%
Shs Float 46.42M
Perf Month -8.84%
Income -172.40M
PEG -
EPS next Q -1.22
Inst Own 98.56%
Short Float 14.46%
Perf Quarter -21.71%
Sales 89.25M
P/S 12.30
EPS this Y -70.21%
Inst Trans -4.11%
Short Ratio 12.66
Perf Half Y -46.90%
Book/sh 9.35
P/B 2.18
EPS next Y 9.18%
ROA -25.26%
Short Interest 6.71M
Perf Year -71.59%
Cash/sh 10.19
P/C 2.00
EPS next 5Y 34.07%
ROE -31.07%
52W Range 19.52 - 76.24
Perf YTD -43.84%
Dividend Est. -
P/FCF -
EPS past 5Y 6.83%
ROI -33.64%
52W High -73.23%
Beta 0.21
Dividend TTM -
Quick Ratio 13.08
Sales past 5Y 4680.14%
Gross Margin 78.39%
52W Low 4.56%
ATR (14) 1.16
Dividend Ex-Date -
Current Ratio 13.08
EPS Y/Y TTM -23.02%
Oper. Margin -242.28%
RSI (14) 43.25
Volatility 5.11% 5.04%
Employees 173
Debt/Eq 0.02
Sales Y/Y TTM 62.51%
Profit Margin -193.17%
Recom 1.44
Target Price 64.75
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q -50.67%
Payout -
Rel Volume 1.06
Prev Close 21.37
Sales Surprise -97.69%
EPS Surprise -15.77%
Sales Q/Q -97.69%
Earnings May 08 AMC
Avg Volume 530.16K
Price 20.41
SMA20 -4.29%
SMA50 -5.85%
SMA200 -38.16%
Trades
Volume 560,036
Change -4.49%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-30-24 Downgrade
BofA Securities
Buy → Neutral
$68 → $38
Dec-12-23 Initiated
Deutsche Bank
Buy
$62
Apr-24-23 Initiated
SVB Securities
Outperform
$80
Jan-27-23 Initiated
Piper Sandler
Overweight
$94
Nov-04-22 Downgrade
RBC Capital Mkts
Outperform → Sector Perform
$52 → $55
Sep-28-22 Upgrade
BofA Securities
Neutral → Buy
Nov-19-21 Initiated
JMP Securities
Mkt Outperform
$77
Jun-18-21 Upgrade
BofA Securities
Underperform → Neutral
$12 → $49
Jun-08-21 Reiterated
Oppenheimer
Outperform
$45 → $54
May-26-21 Initiated
Citigroup
Buy
$39
Feb-26-21 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$14 → $28
Feb-12-21 Upgrade
Jefferies
Hold → Buy
$15 → $30
Feb-02-21 Upgrade
BTIG Research
Neutral → Buy
$29
Dec-07-20 Initiated
H.C. Wainwright
Buy
$22
Jul-09-20 Upgrade
Oppenheimer
Perform → Outperform
$16
Nov-19-19 Upgrade
Evercore ISI
In-line → Outperform
$14
May-21-18 Downgrade
Barclays
Equal Weight → Underweight
$14 → $12
Apr-23-18 Downgrade
Jefferies
Buy → Hold
Apr-05-18 Reiterated
Barclays
Overweight
$70 → $50
Nov-20-17 Downgrade
Wedbush
Outperform → Neutral
$75 → $55
Show Previous Ratings
Jun-11-24 04:07PM
(Investor's Business Daily)
12:20PM
(Investor's Business Daily)
Jun-07-24 11:30AM
May-29-24 10:26AM
08:46AM
(Pharmaceutical Technology)
04:05PM
Loading…
May-28-24 04:05PM
May-09-24 11:52AM
May-08-24 10:56PM
06:10PM
05:14PM
(Associated Press Finance)
04:05PM
May-01-24 04:05PM
Apr-25-24 10:01AM
Apr-15-24 04:05PM
Mar-28-24 08:00AM
(Investor's Business Daily)
04:05PM
Loading…
Mar-05-24 04:05PM
Mar-04-24 04:05PM
Feb-21-24 04:05PM
Feb-16-24 01:33PM
10:33AM
Feb-15-24 04:50PM
(Associated Press Finance)
04:48PM
04:05PM
Feb-08-24 04:05PM
Jan-24-24 11:02PM
Jan-10-24 12:06PM
05:38AM
Jan-08-24 08:30AM
Dec-21-23 09:01AM
Dec-17-23 05:41AM
11:05AM
Loading…
Dec-01-23 11:05AM
Nov-29-23 08:35AM
(Investor's Business Daily)
Nov-20-23 06:00AM
Nov-17-23 01:35PM
08:15AM
(Investor's Business Daily)
Nov-03-23 11:34AM
Nov-02-23 07:03PM
06:25PM
05:24PM
(Associated Press Finance)
04:05PM
Oct-30-23 10:00AM
Oct-26-23 04:09PM
(Investor's Business Daily) -14.62%
04:05PM
10:02AM
05:02AM
Oct-18-23 11:20AM
Oct-17-23 07:57AM
Oct-16-23 11:54AM
11:42AM
Oct-12-23 05:01AM
Oct-07-23 03:33PM
Oct-05-23 09:01AM
Sep-28-23 05:01AM
Sep-19-23 09:01PM
Sep-14-23 01:32PM
Sep-07-23 12:00PM
Aug-31-23 04:05PM
Aug-04-23 09:13AM
Aug-03-23 05:55PM
04:49PM
04:05PM
Aug-02-23 07:57AM
Jul-27-23 04:05PM
Jul-18-23 05:36PM
05:36PM
11:30AM
Jul-17-23 08:35AM
Jul-13-23 09:22AM
Jul-11-23 04:05PM
08:59AM
Jul-10-23 04:10PM
Jul-07-23 09:51AM
Jun-27-23 04:05PM
Jun-12-23 09:25AM
Jun-08-23 12:41PM
Jun-02-23 04:05PM
May-16-23 04:05PM
May-10-23 06:13AM
May-05-23 12:27PM
May-04-23 06:45PM
05:39PM
04:05PM
Apr-27-23 04:05PM
10:02AM
Apr-24-23 04:05PM
Apr-18-23 02:34PM
Apr-14-23 07:30AM
Apr-13-23 08:00AM
Apr-06-23 01:49PM
Mar-31-23 09:20AM
Mar-21-23 04:05PM
Mar-14-23 04:05PM
Mar-01-23 05:20AM
Feb-24-23 11:36AM
Feb-23-23 04:05PM
Feb-16-23 04:05PM
Feb-05-23 05:03AM
Feb-03-23 04:05PM
Feb-01-23 10:48AM
Jan-31-23 04:05PM
Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm's clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Walker Karin L Chief Accounting Officer Jan 24 '24 Option Exercise 13.53 5,000 67,650 5,000 Jan 24 07:01 PM Walker Karin L Chief Accounting Officer Jan 24 '24 Sale 34.00 5,000 170,000 0 Jan 24 07:01 PM Walker Karin L Chief Accounting Officer Dec 20 '23 Option Exercise 13.53 5,000 67,650 5,000 Dec 20 07:17 PM Walker Karin L Chief Accounting Officer Dec 20 '23 Sale 37.19 5,000 185,952 0 Dec 20 07:17 PM Walker Karin L Chief Accounting Officer Nov 30 '23 Option Exercise 13.53 5,000 67,650 5,000 Nov 30 06:24 PM Walker Karin L Chief Accounting Officer Nov 30 '23 Sale 34.00 5,000 170,000 0 Nov 30 06:24 PM Walker Karin L Chief Accounting Officer Oct 25 '23 Option Exercise 13.53 5,000 67,650 5,000 Oct 25 08:03 PM Walker Karin L Chief Accounting Officer Oct 25 '23 Sale 41.04 5,000 205,191 0 Oct 25 08:03 PM Smith Brandon S. Chief Operating Officer Oct 11 '23 Option Exercise 11.12 4,000 44,480 4,000 Oct 11 08:25 PM Smith Brandon S. Chief Operating Officer Oct 11 '23 Sale 46.75 4,000 186,985 0 Oct 11 08:25 PM Karp Carol D. Chief Regulatory Officer Oct 04 '23 Option Exercise 12.15 5,000 60,750 5,000 Oct 04 07:52 PM Karp Carol D. Chief Regulatory Officer Oct 04 '23 Sale 46.62 5,000 233,084 0 Oct 04 07:52 PM Malecek Michael J Chief Legal Officer Sep 27 '23 Option Exercise 10.27 5,000 51,350 5,000 Sep 27 08:35 PM Malecek Michael J Chief Legal Officer Sep 27 '23 Sale 47.38 5,000 236,885 0 Sep 27 08:35 PM Walker Karin L Chief Accounting Officer Sep 19 '23 Option Exercise 15.04 5,000 75,200 5,000 Sep 19 05:37 PM Walker Karin L Chief Accounting Officer Sep 19 '23 Sale 52.36 5,000 261,807 0 Sep 19 05:37 PM Garren Hideki Chief Medical Officer Sep 13 '23 Option Exercise 24.90 2,000 49,800 2,000 Sep 13 07:33 PM Smith Brandon S. Chief Operating Officer Sep 13 '23 Option Exercise 11.12 4,000 44,480 4,000 Sep 13 07:32 PM Smith Brandon S. Chief Operating Officer Sep 13 '23 Sale 55.49 4,000 221,963 0 Sep 13 07:32 PM Garren Hideki Chief Medical Officer Sep 13 '23 Sale 55.48 2,000 110,952 0 Sep 13 07:33 PM Karp Carol D. Chief Regulatory Officer Sep 06 '23 Option Exercise 12.15 5,000 60,750 5,000 Sep 06 07:42 PM Karp Carol D. Chief Regulatory Officer Sep 06 '23 Sale 54.76 5,000 273,804 0 Sep 06 07:42 PM Malecek Michael J Chief Legal Officer Aug 30 '23 Option Exercise 10.27 5,000 51,350 5,000 Aug 30 07:24 PM Malecek Michael J Chief Legal Officer Aug 30 '23 Sale 55.01 5,000 275,066 0 Aug 30 07:24 PM Walker Karin L Chief Accounting Officer Aug 18 '23 Option Exercise 15.04 5,000 75,200 5,000 Aug 18 08:37 PM Walker Karin L Chief Accounting Officer Aug 18 '23 Sale 57.18 5,000 285,922 0 Aug 18 08:37 PM Garren Hideki Chief Medical Officer Aug 16 '23 Option Exercise 24.90 2,000 49,800 2,000 Aug 16 09:15 PM Smith Brandon S. Chief Operating Officer Aug 16 '23 Option Exercise 11.12 4,000 44,480 4,000 Aug 16 09:15 PM Smith Brandon S. Chief Operating Officer Aug 16 '23 Sale 58.71 4,000 234,844 0 Aug 16 09:15 PM Garren Hideki Chief Medical Officer Aug 16 '23 Sale 58.74 2,000 117,480 0 Aug 16 09:15 PM Karp Carol D. Chief Regulatory Officer Aug 02 '23 Option Exercise 12.15 5,000 60,750 5,000 Aug 02 09:00 PM Zago Wagner M. Chief Scientific Officer Aug 02 '23 Option Exercise 12.15 4,000 48,600 4,000 Aug 02 09:00 PM Karp Carol D. Chief Regulatory Officer Aug 02 '23 Sale 67.01 5,000 335,072 0 Aug 02 09:00 PM Zago Wagner M. Chief Scientific Officer Aug 02 '23 Sale 67.05 4,000 268,182 0 Aug 02 09:00 PM Malecek Michael J Chief Legal Officer Jul 26 '23 Option Exercise 10.27 5,000 51,350 5,000 Jul 26 07:45 PM Malecek Michael J Chief Legal Officer Jul 26 '23 Sale 62.33 5,000 311,638 0 Jul 26 07:45 PM Walker Karin L Chief Accounting Officer Jul 19 '23 Option Exercise 15.04 5,000 75,200 5,000 Jul 19 08:50 PM Walker Karin L Chief Accounting Officer Jul 19 '23 Sale 69.19 5,000 345,943 0 Jul 19 08:50 PM Garren Hideki Chief Medical Officer Jul 12 '23 Option Exercise 24.90 2,000 49,800 2,000 Jul 12 08:45 PM Smith Brandon S. Chief Operating Officer Jul 12 '23 Option Exercise 11.12 4,000 44,480 4,000 Jul 12 08:45 PM Smith Brandon S. Chief Operating Officer Jul 12 '23 Sale 67.51 4,000 270,026 0 Jul 12 08:45 PM Garren Hideki Chief Medical Officer Jul 12 '23 Sale 67.51 2,000 135,027 0 Jul 12 08:45 PM Karp Carol D. Chief Regulatory Officer Jul 05 '23 Option Exercise 12.15 5,000 60,750 5,000 Jul 05 09:33 PM Zago Wagner M. Chief Scientific Officer Jul 05 '23 Option Exercise 12.15 4,000 48,600 4,000 Jul 05 09:32 PM Karp Carol D. Chief Regulatory Officer Jul 05 '23 Sale 68.13 5,000 340,636 0 Jul 05 09:33 PM Zago Wagner M. Chief Scientific Officer Jul 05 '23 Sale 68.16 4,000 272,648 0 Jul 05 09:32 PM Selkoe Dennis J. Director Jul 03 '23 Option Exercise 11.33 5,000 56,650 7,845 Jul 03 06:16 PM Selkoe Dennis J. Director Jul 03 '23 Sale 67.43 5,000 337,150 2,845 Jul 03 06:16 PM Malecek Michael J Chief Legal Officer Jun 28 '23 Option Exercise 10.27 5,000 51,350 5,000 Jun 28 08:45 PM Malecek Michael J Chief Legal Officer Jun 28 '23 Sale 69.82 5,000 349,118 0 Jun 28 08:45 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite